Patents Assigned to RUICHUANG BIOTECH.CO., LTD.
  • UNIVERSAL-TYPE EFFICIENT IN-VITRO AMPLIFICATION METHOD FOR MULTIPLE TIMES OF CLINICAL FEEDBACK OF ALLOGENIC DNT CELLS
    Publication number: 20230242875
    Abstract: The present invention relates to a universal-type efficient in-vitro amplification method for multiple times of clinical feedback of allogenic DNT cells. In the method of the present invention, the amount of a T cell activator is phased down in a continuous culture process without the need for additional interleukin-4 or AB serum.
    Type: Application
    Filed: April 14, 2021
    Publication date: August 3, 2023
    Applicant: RUICHUANG BIOTECH.CO., LTD.
    Inventors: Liming Yang, Zhiqiang Xiang, Qinghua Sun